Braskem (BAK) details March 2026 insider share holdings in Form 6-K

Rhea-AI Filing Summary

Braskem S.A. filed a Form 6-K as a foreign private issuer, presenting consolidated information on management and related persons’ holdings in its securities for March 2026 under Article 11 of CVM Instruction 358/2002. The document shows large existing positions in common and Class “A” preferred shares, as well as American depositary receipts, with indications in the checkboxes that no transactions in company securities or derivatives were executed in the period for the marked groups. The report also includes a detailed forward-looking statements disclaimer describing macroeconomic, legal and operational uncertainties that could cause future results to differ from current management expectations.

Key Figures

Common shares reported: 226,334,623 shares Class “A” preferred shares reported: 79,182,498 shares American depositary receipts holding: 167,633 ADRs +3 more

6 metrics

Common shares reported 226,334,623 shares Consolidated common share balance reported for March 2026

Class “A” preferred shares reported 79,182,498 shares Consolidated Class “A” preferred share balance for March 2026

American depositary receipts holding 167,633 ADRs Reported opening or closing balance for a Braskem ADR category

Additional ADR holding 200 ADRs Smaller ADR balance reported for another Braskem category

Technical/advisory preferred shares 5,300 shares Class “A” preferred shares tied to technical or advisory bodies

Report date April 10, 2026 Date the Form 6-K was signed by the CFO

Key Terms

Form 6-K, foreign private issuer, CVM Instruction #358/2002, American depositary receipt, +2 more

6 terms

Form 6-K regulatory

"SECURITIES AND EXCHANGE COMMISSION FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER"

A Form 6-K is a report that companies listed in certain countries file to provide important updates, such as financial results, corporate changes, or other significant information, to regulators and investors. It functions like an official company update or news release, helping investors stay informed about developments that could affect their investment decisions.

foreign private issuer regulatory

"FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16"

A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.

CVM Instruction #358/2002 regulatory

"Management and Related Persons’ Trading of Securities Issued by the Company Article 11 – CVM Instruction #358/2002"

American depositary receipt financial

"Other American depositary receipt 94.770"

An American depositary receipt (ADR) is a certificate that represents shares of a foreign company traded on U.S. stock exchanges. It allows investors to buy and sell parts of a foreign company's stock easily, much like purchasing shares of a company based in their own country. ADRs make international investing more convenient and accessible for U.S. investors.

forward-looking statements regulatory

"DISCLAIMER ON FORWARD-LOOKING STATEMENTS This report on Form 6-K may contain forward-looking statements"

Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

geological event in Alagoas other

"including any potential or projected impact of the geological event in Alagoas and related legal proceedings"

Form 6-K: How Foreign Companies Report to the SEC →

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16
OR 15D-16 OF THE SECURITIES EXCHANGE ACT OF 1934

For the month of April, 2026

(Commission File No. 1-14862 )

BRASKEM S.A.

(Exact Name as Specified in its Charter)

N/A

(Translation of registrant's name into English)

Rua Eteno, 1561, Polo Petroquimico de Camacari
Camacari, Bahia - CEP 42810-000 Brazil

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ___X___       Form 40-F ______

Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(1). _____

Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(7). _____

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ______       No ___X___

If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- _____.

In March/26 ( ) ( x ) Group and Related Persons ( x ) Controlling Shareholders ( ) Board of Directors ( ) Management In March/26 ( ) ( x ) Group and Related Persons ( ) Controlling Shareholders ( x ) Board of Directors ( ) Management Securities/Derivatives Securities Characteristics Share Securities/Derivatives Securities Characteristics Share Class “A” Preferred Share Share Common Share Share Class “A” Preferred Share Securities Characteristics Securities/Derivatives Share Common Share ( ) Fiscal Council Common Share Share Class “A” Preferred Share Opening Balance 226.334.623 79.182.498 Quantity Management and Related Persons’ Trading of Securities Issued by the Company Article 11 – CVM Instruction #358/2002 79.182.498 Quantity Common Share Securities/Derivatives Securities Characteristics CONSOLIDATED FORM Share Share ( ) Fiscal Council Class “A” Preferred Share the following transactions involving securities and derivatives were executed, pursuant to Article 11 - CVM Instruction #358/2002 no transactions involving securities and derivatives were executed, pursuant to Article 11 - CVM Instruction #358/2002 ( ) Technical or Advisory Bodies Opening Balance Management and Related Persons’ Trading of Securities Issued by the Company Article 11 – CVM Instruction #358/2002 - 500 the following transactions involving securities and derivatives were executed, pursuant to Article 11 - CVM Instruction #358/2002 no transactions involving securities and derivatives were executed, pursuant to Article 11 - CVM Instruction #358/2002 Quantity - 500 Closing Balance Quantity Company’s Name: Braskem S.A. ( ) Technical or Advisory Bodies Closing Balance Company’s Name: Braskem S.A. 226.334.623 In March/26 ( ) ( x ) Group and Related Persons ( ) Controlling Shareholders ( ) Board of Directors (x ) Management 94.770 In March/26 ( ) ( x ) Group and Related Persons ( ) Controlling Shareholders ( ) Board of Directors ( ) Management Other American depositary receipt Securities/Derivatives Securities Characteristics Share Common Share Share Common Share Share Class “A” Preferred Share Share Class “A” Preferred Share Securities/Derivatives Securities Characteristics Closing Balance Quantity - 200 Other American depositary receipt 94.770 ( ) Technical or Advisory Bodies Company’s Name: Braskem S.A. Opening Balance Management and Related Persons’ Trading of Securities Issued by the Company Article 11 – CVM Instruction #358/2002 167.633 Closing Balance the following transactions involving securities and derivatives were executed, pursuant to Article 11 - CVM Instruction #358/2002 no transactions involving securities and derivatives were executed, pursuant to Article 11 - CVM Instruction #358/2002 Company’s Name: Braskem S.A. the following transactions involving securities and derivatives were executed, pursuant to Article 11 - CVM Instruction #358/2002 no transactions involving securities and derivatives were executed, pursuant to Article 11 - CVM Instruction #358/2002 Quantity - 167.633 Quantity - ( ) Fiscal Council Securities/Derivatives Securities Characteristics Share Common Share Share Common Share Share Class “A” Preferred Share Share Class “A” Preferred Share Securities/Derivatives ( ) Technical or Advisory Bodies Opening Balance Quantity - 200 Management and Related Persons’ Trading of Securities Issued by the Company Article 11 – CVM Instruction #358/2002 Securities Characteristics ( x ) Fiscal Council In March/26 ( ) ( x ) Group and Related Persons ( ) Controlling Shareholders ( ) Board of Directors ( ) Management - the following transactions involving securities and derivatives were executed, pursuant to Article 11 - CVM Instruction #358/2002 no transactions involving securities and derivatives were executed, pursuant to Article 11 - CVM Instruction #358/2002 Company’s Name: Braskem S.A. ( ) Fiscal Council ( x ) Technical or Advisory Bodies Management and Related Persons’ Trading of Securities Issued by the Company Article 11 – CVM Instruction #358/2002 Opening Balance Securities/Derivatives Securities Characteristics Quantity Share Common Share Share Common Share - Share Class “A” Preferred Share 5.300 Share Class “A” Preferred Share 5.300 Closing Balance Securities/Derivatives Securities Characteristics Quantity

 

 

SIGNATURES

        Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: April 10, 2026

	BRASKEM S.A.
	By:	/s/     Felipe Montoro Jens
		Name:	Felipe Montoro Jens
		Title:	Chief Financial Officer

DISCLAIMER ON FORWARD-LOOKING STATEMENTS

This report on Form 6-K may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are statements that are not historical facts, and are based on our management’s current view and estimates of future economic and other circumstances, industry conditions, company performance and financial results, including any potential or projected impact of the geological event in Alagoas and related legal proceedings and of COVID-19 on our business, financial condition and operating results. The words “anticipates,” “believes,” “estimates,” “expects,” “plans” and similar expressions, as they relate to the company, are intended to identify forward-looking statements. Statements regarding the potential outcome of legal and administrative proceedings, the implementation of principal operating and financing strategies and capital expenditure plans, the direction of future operations and the factors or trends affecting our financial condition, liquidity or results of operations are examples of forward-looking statements. Such statements reflect the current views of our management and are subject to a number of risks and uncertainties, many of which are outside of the our control. There is no guarantee that the expected events, trends or results will actually occur. The statements are based on many assumptions and factors, including general economic and market conditions, industry conditions, and operating factors. Any changes in such assumptions or factors, including the projected impact of the geological event in Alagoas and related legal proceedings and the unprecedented impact of COVID-19 pandemic on our business, employees, service providers, stockholders, investors and other stakeholders, could cause actual results to differ materially from current expectations. Please refer to our annual report on Form 20-F for the year ended December 31, 2019 filed with the SEC, as well as any subsequent filings made by us pursuant to the Exchange Act, each of which is available on the SEC’s website (www.sec.gov), for a full discussion of the risks and other factors that may impact any forward-looking statements in this presentation.

FAQ

What does Braskem (BAK) report in this April 2026 Form 6-K?

Braskem’s Form 6-K provides a consolidated snapshot of share and derivative holdings by management, board-related groups and advisory bodies for March 2026. It is a regulatory transparency report, not an earnings release or major transaction announcement, and mainly lists positions and standard legal disclaimers.

Did Braskem (BAK) management trade company securities in March 2026?

The filing’s checked boxes state that no transactions involving securities or derivatives issued by Braskem were executed in March 2026 for the indicated groups. Instead, the document focuses on reporting opening and closing balances in common shares, preferred shares and related instruments during that period.

What share holdings are disclosed for Braskem (BAK) in this 6-K?

Braskem discloses large consolidated positions including 226,334,623 common shares and 79,182,498 Class “A” preferred shares, along with smaller holdings in American depositary receipts and other categories. These figures reflect reported balances for groups such as management, fiscal council and technical or advisory bodies.

What is CVM Instruction 358/2002 referenced by Braskem (BAK)?

CVM Instruction 358/2002 is a Brazilian securities regulation governing disclosure of material information and trading by management and related persons. Braskem’s 6-K reproduces forms required under Article 11, detailing positions and potential trades in company securities held by insiders and related parties during March 2026.

Does Braskem’s April 2026 6-K include forward-looking statements?

Yes. Braskem includes a detailed forward-looking statements disclaimer citing the U.S. Private Securities Litigation Reform Act of 1995. It notes that expectations about economic conditions, legal proceedings, the Alagoas geological event and COVID-19 impacts are uncertain and may differ materially from actual future results.